The outlook of companies tied to flagship drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial https://joanjmcy491541.targetblogs.com/41517221/the-blue-pill-and-big-pharma-a-risky-investment